Tang Carolyn C.
SEC insider (Form 3/4/5 filer). CIK 0001836662. General Counsel at Arcus Biosciences, Inc. (RCUS). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in HAYWARD, CA.
Companies Tang Carolyn C. has filed insider reports for
- Arcus Biosciences, Inc. (RCUS): Officer, General Counsel
Tang Carolyn C.
CIK: 0001836662
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)1 (16.7%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (16.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RCUS
Arcus Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 11, 2026RCUS
Arcus Biosciences, Inc.
ExerciseDirect34.1K shares at avg. $2.57$88K - Jan 23, 2026RCUS
Arcus Biosciences, Inc.
AwardDirect24K shares- - Dec 17, 2025RCUS
Arcus Biosciences, Inc.
SaleDirect6.8K shares at avg. $22.16$151K - Dec 16, 2025RCUS
Arcus Biosciences, Inc.
SaleDirect7.7K shares at avg. $21.88$168K - Jan 23, 2025RCUS
Arcus Biosciences, Inc.
AwardDirect37K shares- - Dec 15, 2024RCUS
Arcus Biosciences, Inc.
Tax PaymentDirect11.3K shares at avg. $16.08$182K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | RCUS Arcus Biosciences, Inc. | Exercise | 34,090 | $2.57 | $87,748 | Direct |
| Jan 23, 2026 | RCUS Arcus Biosciences, Inc. | Award | 24,000 | - | $0 | Direct |
| Dec 17, 2025 | RCUS Arcus Biosciences, Inc. | Sale | 6,810 | $22.16 | $150,906 | Direct |
| Dec 16, 2025 | RCUS Arcus Biosciences, Inc. | Sale | 7,658 | $21.88 | $167,590 | Direct |
| Jan 23, 2025 | RCUS Arcus Biosciences, Inc. | Award | 37,000 | - | $0 | Direct |
| Dec 15, 2024 | RCUS Arcus Biosciences, Inc. | Tax Payment | 11,339 | $16.08 | $182,331 | Direct |
1-6 of 6 transactions